Protease Inhibitors: all 1,856 studies that test it
Page 17 of 19. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)WithdrawnNCT00387972Phase 2/3
- Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.TerminatedNCT00386659Phase 4
- Atazanavir or Lopinavir in HIV Post-exposure ProphylaxisCompletedNCT00385645Phase 4
- Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected PatientsCompletedNCT00384904Phase 4
- Saquinavir/Ritonavir in Single Therapy as Maintenance TreatmentCompletedNCT00379405Phase 4
- Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye SyndromeCompletedNCT00370747Phase 2
- Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/TenofovirCompletedNCT00365339Phase 1
- Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate RosiglitazoneCompletedNCT00362726Phase 1
- Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug IndinavirCompletedNCT00362310Phase 2
- Can Aprotinin Reduce Pancreatitis After Scoliosis SurgeryCompletedNCT00357851Phase 1
- Atazanavir Twice DailyCompletedNCT00357721Phase 1
- Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy FemalesCompletedNCT00357604Phase 1
- Drug Interaction Study With Proton Pump InhibitorCompletedNCT00357240Phase 1
- Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy SubjectsCompletedNCT00357188Phase 1
- Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV PatientsCompletedNCT00355719Phase 4
- A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and AdolescentsCompletedNCT00355524Phase 2
- Phase I Study of Aprotinin in Advanced Breast CancerTerminatedNCT00354900Phase 1
- Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in AdultsCompletedNCT00346619Phase 1
- The Effects of HIV Protease Inhibitors in Severe SepsisCompletedNCT00346580Phase 1
- Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy SubjectsCompletedNCT00344123Phase 1
- Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion SurgeryTerminatedNCT00327379Phase 3
- A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic SyndromeTerminatedNCT00312754Phase 4
- Thorough QT Study of NelfinavirCompletedNCT00312182Phase 4
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedNCT00307502Phase 1
- Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total CystectomyTerminatedNCT00306150Phase 3
- Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal CancerTerminatedNCT00306137Phase 3
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
- Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)CompletedNCT00290836Phase 4
- Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00290017Phase 3
- Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy MenCompletedNCT00287833Phase 1
- A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus CapsulesCompletedNCT00281606Phase 4
- Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV TreatmentCompletedNCT00280969Phase 3
- 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining StudyCompletedNCT00275444Phase 2
- Drug Interaction Study Between Antimalarial and Anti-HIV MedicationsCompletedNCT00266058Phase 1
- Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis CCompletedNCT00262483Phase 2
- Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.CompletedNCT00261391Phase 1
- Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedNCT00260078Phase 1/2
- GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected AdultsCompletedNCT00257621Phase 2
- VX-950 and Peginterferon for Hepatitis CCompletedNCT00251199Phase 1
- High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV DiseaseStatus unknownNCT00247143Not applicable
- Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During PregnancyCompletedNCT00246610Phase 4
- Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00244322Phase 2
- Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00243204Phase 3
- A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced AdultsTerminatedNCT00242879Phase 2
- Fosamprenavir Expanded AccessCompletedNCT00240552Phase 4
- Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir ScoreCompletedNCT00234975Phase 4
- Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral TherapyTerminatedNCT00234962Phase 4
- When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
- Boosted Atazanavir and Truvada Given Once-Daily - BATON StudyCompletedNCT00224445Phase 4
- Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in JapanCompletedNCT00219375Phase 4
- Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765CompletedNCT00205465Phase 2
- Nelfinavir and M8 Drug-level Monitoring in HIV-1 InfectionCompletedNCT00205283Not applicable
- Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye SyndromeCompletedNCT00198536Phase 2/3
- Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure.CompletedNCT00196625Phase 2
- ATV/Ritonavir Nevirapine Interaction (USPAC)CompletedNCT00162149Phase 1
- Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With HyperlipidemiaCompletedNCT00160329Phase 3
- Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled HypertensionCompletedNCT00160225Phase 2
- Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionCompletedNCT00160212Phase 2
- A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and AmprenavirCompletedNCT00148785Phase 4
- The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.CompletedNCT00145561Phase 1/2
- Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsTerminatedNCT00144833Phase 3
- Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment OptionsCompletedNCT00144287Phase 3
- NRTI-Sparing Pilot StudyCompletedNCT00143689Phase 4
- Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected PatientsCompletedNCT00140751Phase 3
- Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin MetabolismCompletedNCT00135434Phase 1
- A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART RegimenCompletedNCT00135395Phase 3
- Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary BypassCompletedNCT00131040Not applicable
- Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected WomenCompletedNCT00125983Phase 2
- Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)CompletedNCT00122603Phase 2
- Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected PatientsTerminatedNCT00122577Phase 2
- A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected SubjectsWithdrawnNCT00121017Phase 2
- Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/RitonavirCompletedNCT00120393Phase 3
- Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult PatientsCompletedNCT00116636Phase 2
- Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the PancreasTerminatedNCT00116389Phase 2
- TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment OptionsCompletedNCT00115050Phase 3
- TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced PatientsCompletedNCT00110877Phase 3
- Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and WomenCompletedNCT00102986Not applicable
- GW873140 In Combination With Kaletra In HIV Infected SubjectsTerminatedNCT00102778Phase 2
- Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid TumorsTerminatedNCT00100347Phase 1
- A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)TerminatedNCT00100152Phase 1
- Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected AdultsCompletedNCT00096850Not applicable
- Study Evaluating TMI-005 in Active Rheumatoid ArthritisCompletedNCT00095342Phase 2
- Fosamprenavir Versus Other Protease InhibitorsCompletedNCT00094523Phase 3
- Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIVCompletedNCT00086359Phase 3
- Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)CompletedNCT00086203Phase 2
- KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNCT00085943Phase 3
- Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive PatientsCompletedNCT00084253Phase 4
- Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIVCompletedNCT00084058Phase 1/2
- Atazanavir/Ritonavir Maintenance TherapyCompletedNCT00084019Not applicable
- Study of Talabostat and Cisplatin in Advanced MelanomaCompletedNCT00083252Phase 2
- Study of Talabostat in Advanced MelanomaCompletedNCT00083239Phase 2
- A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIVCompletedNCT00082394Phase 4
- An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.CompletedNCT00081588Phase 2
- Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired PneumoniaCompletedNCT00080496Phase 3
- Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung CancerCompletedNCT00080080Phase 2
- Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung CancerCompletedNCT00078390Phase 1/2
- A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected SubjectsCompletedNCT00075231Phase 2
- A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral TherapyCompletedNCT00067782Phase 3
- Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected PatientsCompletedNCT00056641Phase 2
- Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral RegimensCompletedNCT00052117Phase 2